[Federal Register Volume 66, Number 194 (Friday, October 5, 2001)]
[Notices]
[Pages 51049-51050]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-25050]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


ICD-9-CM Coordination and Maintenance Committee Meeting

    National Center for Health Statistics (NCHS), Data Policy and 
Standards Staff, announces the following meeting.

    Name: ICD-9-CM Coordination and Maintenance Committee meeting.
    Times and Dates: 9 a.m.-5 p.m., November 1-2, 2001.
    Place: Centers for Medicare and Medicaid Services (CMS)(formerly 
The Health Care Financing Administration) Auditorium, 7500 Security 
Boulevard, Baltimore, Maryland.
    Status: Open to the public.
    Purpose: The ICD-9-CM Coordination and Maintenance (C&M) 
Committee will hold its final meeting of the 2001 calendar year 
cycle on Thursday and Friday Nov. 1-2, 2001. The C&M meeting is a 
public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Ninth-Revision, Clinical 
Modification.
    Matters To Be Discussed: Agenda items include:

Discussion on use of V codes for procedures
Heart failure
Aftercare codes
Vascular disease
Facial droop following CVA
Ectopic pregnancy with uterine pregnancy
Pulmonary complications of cystic fibrosis
Asthma
Severe sepsis
West Nile Virus
Paint ball injury
Abnormal pap smear
ICD-10-PCS Update
Implantation of intramuscular electrodes
Brain wafer chemotherapy
Cardiac resynchronization therapy
Implantation of neosphincter
Spinal procedures-360 fusion, Interbody Fusion Devices, InFUSE bone 
grafts
Repair of Aneurysm/Arteriovenous malformation
Hepatic hemodialysis
Therapeutic ultrasound
Infusion of Drotrecogin Alfa (Activated)
Adhesion barriers for abdominal surgery
Extra-corporeal immunoadsorption (ECI)
Intraoperative MRI
Administration of inhaled nitric oxide
Drug-Eluting stent
Injection or infusion of Human B-type natriuretic peptide (hBNP)
Addenda

    For Further Information Contact: Amy Blum, Medical 
Classification Specialist, Data Policy and Standards Staff, NCHS, 
6526 Belcrest Road, Room 1100, Hyattsville, Maryland 20782, 
telephone 301/458-4106 (diagnosis), Amy Gruber, Health Insurance 
Specialist, Division of Acute Care, CMS, 7500

[[Page 51050]]

Security Blvd., Room C4-07-07, Baltimore, Maryland, 21244 telephone 
410-786-1542 (procedures).
    Notice: In the interest of security, (CMS) has instituted 
stringent procedures for entrance into the building by non-
government employees. Persons without a government I.D. will need to 
show a photo I.D. and sign-in at the security desk upon entering the 
building.
    Notice: This is a public meeting. However, because of fire code 
requirements, should the number of attendants meet the capacity of 
the room the meeting will be closed.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: October 1, 2001.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 01-25050 Filed 10-4-01; 8:45 am]
BILLING CODE 4160-18-P